Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Medical Hypotheses
|
July 11, 2020
Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole
James J DiNicolantonio, Jorge Barroso-Aranda
Chemical Society Reviews
|
January 14, 2022
Structural transformations in boron clusters induced by metal doping
Jorge Barroso, Sudip Pan, Gabriel Merino
Open Heart
|
September 8, 2020
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
James J DiNicolantonio, Jorge Barroso, Mark McCarty
Medical Hypotheses
|
June 6, 2007
PPAR gamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
January 22, 2010
Practical strategies for suppressing hypoxia-inducible factor activity in cancer therapy
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
July 7, 2009
NADPH oxidase mediates glucolipotoxicity-induced beta cell dysfunction--clinical implications
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
July 3, 2009
Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
February 4, 2009
Can moderate elevations of parathyroid hormone acutely increase risk for ischemic cardiac arrhythmias?
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
February 11, 2009
Regular thermal therapy may promote insulin sensitivity while boosting expression of endothelial nitric oxide synthase--effects comparable to those of exercise training
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
May 16, 2007
A two-phase strategy for treatment of oxidant-dependent cancers
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Medical Hypotheses
|
July 11, 2020
Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole
James J DiNicolantonio, Jorge Barroso-Aranda
Chemical Society Reviews
|
January 14, 2022
Structural transformations in boron clusters induced by metal doping
Jorge Barroso, Sudip Pan, Gabriel Merino
Open Heart
|
September 8, 2020
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
James J DiNicolantonio, Jorge Barroso, Mark McCarty
Medical Hypotheses
|
June 6, 2007
PPAR gamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
January 22, 2010
Practical strategies for suppressing hypoxia-inducible factor activity in cancer therapy
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
July 7, 2009
NADPH oxidase mediates glucolipotoxicity-induced beta cell dysfunction--clinical implications
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
July 3, 2009
Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
February 4, 2009
Can moderate elevations of parathyroid hormone acutely increase risk for ischemic cardiac arrhythmias?
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
February 11, 2009
Regular thermal therapy may promote insulin sensitivity while boosting expression of endothelial nitric oxide synthase--effects comparable to those of exercise training
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Medical Hypotheses
|
May 16, 2007
A two-phase strategy for treatment of oxidant-dependent cancers
Mark F McCarty, Jorge Barroso-Aranda, Francisco Contreras
Page
of 8